DƯỢC LÍ Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th, 2010

ELECTRONIC PRESCRIBING
The era of e-prescribing has begun. Its implementation
is still expensive, but the subsequent benefits to patients
and savings in personnel costs, along with its integration
with electronic medical records, drug inventory
control, and billing, point to the wide use of e-prescribing
in the future. Computerized prescription ordering eliminates
some of the subjective features of prescribing.
Thus, if the proper information is entered correctly in
the electronic system, medication errors due to illegible
handwriting, incorrect dose, incorrect medication
for medical condition, and drug interactions can be
reduced, because each prescription can be linked to
high-quality drug databases that check that the information
on the prescription is appropriate for the patient
(e.g., age, weight, gender, condition, lab values, disease
being treated, concurrent medications) and that known
warnings and potential problems are brought to the
attention of the physician, pharmacist, and patient. Such
systems must not be used as a substitute for personal
attention to the individual patient by healthcare workers
but, rather, as an adjunct measure that ensures safe,
high-quality, efficient care.
REFERENCES
Bunting BA, Smith BH, Sutherland SE. The Asheville Project:
Clinical and economic outcomes of a community-based
long-term medication therapy management program for
hypertension and dyslipidemia. J Am Pharm Assoc, 2008,
48:23–31.
Chedoe I, Molendijk HA, Dittrich ST, et al. Incidence and nature
of medication errors in neonatal intensive care with strategies
to improve safety: A review of the current literature. Drug Saf,
2007, 30:503–513.
Cohen MR. The Institute of Medicine report, preventing medication
errors: Another good day. Am J Health Syst Pharm,
2007, 64(suppl):S1–S2.
Conroy S, Sweis D, Planner C, et al. Interventions to reduce dosing
errors in children: A systematic review of the literature.
Drug Saf, 2007, 30:1111–1125.
Curtis LH, Ostbye T, Sendersky V, et al. Inappropriate prescribing
for elderly Americans in a large outpatient population.
Arch Intern Med, 2004, 164:1621–1625.
Dijkstra A, Okken V, Niemeijer M, Cleophas T. Determinants of
perceived severity of hypertension and drug-compliance in
hypertensive patients. Cardiovasc Hematol Disord Drug
Targets, 2008, 8:179–184.
Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria
for potentially inappropriate medication use in older
adults: Results of a US consensus panel of experts. Arch Intern
Med, 2003, 163:2716–2724.
Findlay SD. Direct-to-consumer promotion of prescription drugs.
Economic implications for patients, payers and providers.
Pharmacoeconomics, 2001, 19:109–119.
Hagstrom B, Mattsson B, Rost IM, Gunnarsson RK. What happened
to the prescriptions? A single, short, standardized telephone
call may increase compliance. Fam Pract, 2004,
21:46–50.
Hobbs RE. Guidelines for the diagnosis and management of
heart failure. Am J Ther, 2004, 11:467–472.
Khanfar N, Loudon D, Sircar-Ramsewak F. FDA direct-toconsumer
advertising for prescription drugs: What are consumer
preferences and response tendencies? Health Mark Q,
2007, 24:77–91.
Klein A, Otto G, Kramer I. Impact of a pharmaceutical care program
on liver transplant patients’ compliance with immunosuppressive
medication: A prospective, randomized, controlled
trial using electronic monitoring. Transplantation, 2009, 87:
839–847.
Koczmara C, Jelincic V, Dueck C. Dangerous abbreviations: “U”
can make a difference! Dynamics, 2005, 16:11–15.
Kohn LT. The Institute of Medicine report on medical error:
Overview and implications for pharmacy. Am J Health Syst
Pharm, 2001, 58:63–66.
Kohn LT, Findlay SD, Donaldson MS. To Err Is Human:
Building a Safer Health System. Washington, DC, National
Academy Press, 2000.
Kuperman GJ, Teich JM, Gandhi TK, Bates DW. Patient safety
and computerized medication ordering at Brigham and
Women’s Hospital. Jt Comm J Qual Improv, 2001, 27:509–521.
Lesar TS, Briceland L, Stein DS. Factors related to errors in
medication prescribing. JAMA, 1997, 277:312–317.
Lopez R, Goldoftas B. The urban elderly in the United States:
Health status and the environment. Rev Environ Health, 2009,
24:47–57.
Mangino PD. Role of the pharmacist in reducing medication
errors. J Surg Oncol, 2004, 88:189–194.
Michalsen A, Delclos GL, Felknor SA. Compliance with universal
precautions among physicians. J Occup Environ Med,
1997, 39:130–137.
Murray MD, Ritchey ME, Wu J, Tu W. Effect of a pharmacist on
adverse drug events and medication errors in outpatients with
cardiovascular disease. Arch Intern Med, 2009, 169:757–763.
O’Mahony D, Gallagher PF. Inappropriate prescribing in the
older population: Need for new criteria. Age Ageing, 2008,
37:138–141.
Restrepo RD, Alvarez MT, Wittnebel LD, et al. Medication
adherence issues in patients treated for COPD. Int J Chron
Obstruct Pulmon Dis, 2008, 3:371–384.
Sox NC, Woloshin S. How many deaths are due to medical error?
Getting the number right. Eff Clin Pract, 2000, 3:277–283.
Teichman PG, Caffee AE. Prescription writing to maximize
patient safety. Fam Pract Manag, 2002, 9:27–30.
Topol EJ. Failing the public health—Rofecoxib, Merck, and the
FDA. N Engl J Med, 2004, 351:1707–1709.
Tzimenatos L, Bond GR. Severe injury or death in young children
from therapeutic errors: A summary of 238 cases from
the American Association of Poison Control Centers. Clin
Toxicol (Phila), 2009, 47:348–354.
Zyczynski TM, Coyne KS. Hypertension and current issues in
compliance and patient outcomes. Curr Hypertens Rep, 2000,
2:510–514.
1889
APPENDIX I
PRINCIPLES OF PRESCRIPTION ORDER WRITING AND PATIENT COMPLIANCE